Last reviewed · How we verify
NCT05715502: FocaSaBra
Focal Salvage Brachytherapy Study (FocaSaBra)
NA trial testing brachytherapy in Prostate Cancer in 100 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | The Greater Poland Cancer Centre |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 May 2022 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2028 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- brachytherapy — full drug profile →
Conditions studied
- Prostate Cancer — all drugs for Prostate Cancer →
Sponsor
The Greater Poland Cancer Centre — full company profile →
Who can join
18 and older, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this prospective phase II study is to evaluate the toxicity of salvage partial (focal) prostate brachytherapy in patients after prior radiotherapy (standard teleradiotherapy with / without brachytherapy, hypofractionated, self-reactive HDR / LDR brachytherapy) with local recurrence on the part of the prostate gland.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation.
Meraouna Y, Blanchard P, Losa S, Labib A, et al · · 2024 · PMID 39027689 · DOI 10.1016/j.ctro.2024.100809
Verify or expand the search:
- PubMed search for NCT05715502
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of brachytherapy
Trials testing the same drug.
- NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
- NCT06524778 — Single High-dose Brachytherapy for Giant Osteosarcoma Masses · Phase 2 · not yet recruiting
- NCT06752135 — Node Positive Cervical Cancer Treated by Neoadjuvant Chemotherapy Plus Radical Surgery: a Single Center Experience · terminated
- NCT05105672 — A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer · Phase 2 · unknown
- NCT03469531 — Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer · Phase 2 · unknown
Other recruiting trials for Prostate Cancer
Currently open trials in the same condition.
- NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
- NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
- NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
- NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
- NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting
Other The Greater Poland Cancer Centre trials
Trials by the same sponsor.
- NCT07011316 — Subclinical Monitoring of Lymphatic Function in Oncology Patients for Lymphoedema Prevention (ONCOLYMPH) · recruiting
- NCT05142202 — High Five (HiFi) Accelerated Partial Breast Irradiation Study · NA · unknown
- NCT05192447 — The Cognitive-Behavioral Dysfunctions and the Potential of Neuroplasticity in Brain Tumors Patients During Radiotherapy · NA · unknown
- NCT04683549 — HPV Serum Level and FDG PET CT in Patients With Cervical Cancer Treated With Radical Radiochemotherapy · NA · unknown
- NCT06190600 — Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05715502 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Greater Poland Cancer Centre
- Last refreshed: 30 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05715502.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing